
zzso therapy for solid tumors could benefit from an in zzso model that defines tumor characteristics of responsiveness and resistance to facilitate patient zzso Here we report that combining the zzso zzso inhibitor zzso with the zzso agent zzso profoundly affected growth of zzso zzso lung zzso zzso zzso in zzso nude rats by targeting and zzso zzso cells that occupied up to zzso of the tumor zzso A similar reduction in tumor burden was seen with zzso therapy in zzso or zzso zzso tumors growing zzso Increased expression of zzso genes and the zzso zzso inhibitor zzso was zzso Hundreds of genes were zzso highlighted by the zzso of zzso genes coding for zzso factor binding proteins and the zzso zzso a key regulator of the cell zzso zzso significant gene expression changes were seen in key regulatory pathways involved in cell cycle, DNA damage, zzso and tissue zzso These findings show the promise for zzso therapy in cancer management and provide an zzso lung cancer model that can assess therapeutic efficacy and zzso of the zzso in tumors harboring different genetic and zzso profiles to guide use of these zzso 

